title: Kinetic analysis of the transport of salicylic acid, a nonsteroidal anti-inflammatory drug, across human placenta.
abstract: The aim of this study was to develop a pharmacokinetic model to describe the transplacental transfer of drugs, based on the human placental perfusion study. The maternal and fetal sides of human placentas were perfused with salicylic acid together with antipyrine, a passive diffusion marker. The drug concentration in the placental tissue was determined at the end of perfusion. A compartment model consisting of maternal space, fetal intravascular space, and placental tissue was fitted to the observed concentration profiles of salicylic acid in the maternal and fetal effluents. The developed model could adequately explain the concentration profiles of salicylic acid in the effluents with influx clearances from maternal and fetal perfusates to placental tissue of 0.0407 and 0.0813 ml/min/g cotyledon and efflux rate constants from placental tissue to maternal and fetal perfusates (k2 and k3) of 0.0238 and 0.176 min(-1), respectively. The kinetics of antipyrine was adequately described by assuming rapid equilibrium between fetal perfusate and placental tissue compartments. The influx plasma clearance from the maternal side (K''1) in humans was estimated by taking into account the protein binding. The K''1/k2 value of salicylic acid was 1.07 ml/g cotyledon and was larger than that of antipyrine (0.642 ml/g cotyledon). We evaluated the transplacental transfer kinetics of salicylic acid by human placental perfusion study with various perfusion protocols. Based on the data obtained, we developed a pharmacokinetic model, which should enable us to estimate the influx profile of drugs into umbilical arterial blood from the maternal plasma concentration profile.
authors.affiliation: Department of Medico-Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
authors.forename: Kyohei
authors.initials: K
authors.lastname: Shintaku
authors.forename: Yuka
authors.initials: Y
authors.lastname: Arima
authors.forename: Yukihiko
authors.initials: Y
authors.lastname: Dan
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Takeda
authors.forename: Kentaro
authors.initials: K
authors.lastname: Kogushi
authors.forename: Masayuki
authors.initials: M
authors.lastname: Tsujimoto
authors.forename: Hideaki
authors.initials: H
authors.lastname: Nagata
authors.forename: Shoji
authors.initials: S
authors.lastname: Satoh
authors.forename: Kiyomi
authors.initials: K
authors.lastname: Tsukimori
authors.forename: Hitoo
authors.initials: H
authors.lastname: Nakano
authors.forename: Satoko
authors.initials: S
authors.lastname: Hori
authors.forename: Hisakazu
authors.initials: H
authors.lastname: Ohtani
authors.forename: Yasufumi
authors.initials: Y
authors.lastname: Sawada
mesh_terms: D000465:Algorithms; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism* / Q000493:pharmacokinetics; D000983:Antipyrine / Q000378:metabolism / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D007700:Kinetics; D008954:Models, Biological; D010477:Perfusion / Q000379:methods; D010539:Permeability; D010920:Placenta / Q000378:metabolism*; D011247:Pregnancy; D020156:Salicylic Acid / Q000378:metabolism* / Q000493:pharmacokinetics; D013997:Time Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D020156:Salicylic Acid; D000983:Antipyrine